DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, proposed the engineering concept of digital qubits. Unlike physical qubits that rely on physical ...
Quantum computers are closer than ever. The year 2026 has been internationally designated the "Year of Quantum Security" -- ...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence ('AI”) to develop ...
Over five frantic days, I gambled my family’s life savings on a hunch that A.I. could outperform a real estate agent.
IAB UK forecasts AI will drive one-third of UK digital ad spend by 2030 as advertisers adapt to changes in search, content ...
Meanwhile, the authors estimate that by 2030, AI infrastructure will generate 2.5 million tonnes of electronic waste per year ...
As Ukraine chips away at Russian supply lines and oil infrastructure, Western analysts say the Kremlin’s hopes of a rapid ...
Under the TRIDENT (Tracking & Resilient Inertial-Derived Estimation for Naval Targets) contract, Tycho.AI will deliver a robust, multi-domain navigation and long-range Intelligence, Surveillance, and ...
Oricell Therapeutics, a clinical-stage biotech company pioneering cancer immunotherapy, today announced that its lead asset, ...
Jefferies Global Healthcare Conference 2026 June 3, 2026 9:55 AM EDTCompany ParticipantsWayde McMillan - Executive VP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results